Skip to content

uniQure QURE Cash ratio

Cash ratio at other companies

Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
0.5×+0.1×
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
3.5×+2.9×
PTC Therapeutics logo
PTC TherapeuticsPTCT
0.9×-1.6×
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
3.1×+1.1×
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
4.7×+0.8×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
1.1×-2.5×

Other financials

Income statement

See full
Revenue$3.6M+127%
Gross profit$3.3M+144%
Operating income-$45.7M-16.2%
Net income-$53.5M-22.7%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$140.0M-35.6%
Total debt$63.3M-4.3%
Total equity$149.3M+343%
Total assets$778.7M+28.6%

Cash flow

See full
Operating cash flow-$38.2M+13.3%
CapEx$140.0K+11.1%
Free cash flow-$38.4M+13.2%

Valuation

See full
Market cap$3.09B+78.4%
Enterprise value$3.02B+124%
P/S170.9×+85.1×

Profitability

See full
Gross margin90.6%-2.9pp
Operating margin-1,059.7%+380pp
Net margin-1,154.4%+89.3pp
FCF margin-953.7%+169pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.4×-1.5×
Current ratio10.4×-1.6×

Where this comes from

Calculated from uniQure’s reported figures.

Based on the most recent quarter.

The official record: uniQure’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about uniQure's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is uniQure's cash ratio?
uniQure (QURE) reported cash ratio of 2.4× in Q1 2026.
How has uniQure's cash ratio changed year-over-year?
uniQure's cash ratio decreased by 60.5% year-over-year, from 6× to 2.4×.
What is the long-term trend for uniQure's cash ratio?
Over 5 years (2020 to 2025), uniQure's cash ratio has grown at a -32.3% compound annual growth rate (CAGR), from 9× to 1.3×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.